Assembly Biosciences (ASMB) Operating Income (2016 - 2025)
Historic Operating Income for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to -$10.9 million.
- Assembly Biosciences' Operating Income rose 66.63% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.4 million, marking a year-over-year increase of 643.86%. This contributed to the annual value of -$45.4 million for FY2024, which is 2974.04% up from last year.
- Per Assembly Biosciences' latest filing, its Operating Income stood at -$10.9 million for Q3 2025, which was up 66.63% from -$11.1 million recorded in Q2 2025.
- In the past 5 years, Assembly Biosciences' Operating Income ranged from a high of -$9.9 million in Q1 2025 and a low of -$62.9 million during Q4 2021
- Its 4-year average for Operating Income is -$18.3 million, with a median of -$12.6 million in 2023.
- In the last 5 years, Assembly Biosciences' Operating Income crashed by 45972.03% in 2021 and then soared by 4514.55% in 2024.
- Assembly Biosciences' Operating Income (Quarter) stood at -$62.9 million in 2021, then skyrocketed by 80.04% to -$12.6 million in 2023, then rose by 8.12% to -$11.5 million in 2024, then rose by 5.63% to -$10.9 million in 2025.
- Its Operating Income was -$10.9 million in Q3 2025, compared to -$11.1 million in Q2 2025 and -$9.9 million in Q1 2025.